AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 1096922
Drug: Standard local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard local anaesthetic agent
Trial: 25554994
Drug: venlafaxine extended-release
RxNorm normalized name: Desvenlafaxine Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: venlafaxine extended-release
Trial: 23185988
Drug: More than
RxNorm normalized name: polyurethane-35 (not more than MPA.S at 40 %)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: More than one line of chemotherapy
Trial: 22027749
Drug: Myocet (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myocet (60 mg/m intravenously on day 1 every 4 weeks)
Trial: 15142030
Drug: 1.5 g
RxNorm normalized name: Vaporizer Vicks 1.5 gal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g carbohydrate (CHO)/kg body mass carbohydrate beverage (25% solution)
Trial: 11517127
Drug: EPO therapy
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO therapy (100 U x kg(‐1) s.c. three times a week for 3 weeks before surgery and i.v. on the day of surgery)
Trial: 2629624
Drug: Cereal based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cereal based oral rehydration solution (made of maize, millet, sorghum, or rice)
Trial: 2629624
Drug: World Health
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: World Health Organisation/United Nations Childrens Fund (WHO/Unicef) recommended oral rehydration solution
Trial: 786421
Drug: Disulfiram implants
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disulfiram implants
Trial: 31236778
Drug: Intraarticular analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular analgesic infusion (IAC) (Group II, n=172 patients)
Trial: 23757614
Drug: Low-dose vitamin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose vitamin C (250 mg/day)
Trial: 23757614
Drug: Medium-dose vitamin
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-dose vitamin C (500 mg/day)
Trial: 23757614
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin C (1,000 mg/day)
Trial: 6354933
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg three times daily (t.i.d.)
Trial: 6354933
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg twice daily (b.i.d.)
Trial: 6354933
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg three times daily (t.i.d.)
Trial: 6354933
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg twice daily (b.i.d.)
Trial: 6354933
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg three times daily (t.i.d.) with chlorthalidone 25 mg daily
Trial: 6354933
Drug: Captopril 25
RxNorm normalized name: captopril 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 25 mg twice daily (b.i.d.) with chlorthalidone 25 mg daily
Trial: 31875936
Drug: Baseline UA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline UA levels < 5.0 mg/dL
Trial: 31875936
Drug: Baseline UA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline UA levels 5.0-6.0 mg/dL
Trial: 31875936
Drug: Baseline UA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline UA levels 6.0-7.0 mg/dL
Trial: 31875936
Drug: Baseline UA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline UA levels ≥ 7.0 mg/dL
Trial: 30779295
Drug: Sildenafil (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (25 mg orally three times daily until 32+0 weeks, birth, or fetal death)
Trial: 30779295
Drug: Placebo (visually
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (visually matching placebo three times daily until 32+0 weeks, birth, or fetal death)
Trial: 26280699
Drug: Ozonated oil
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozonated oil and α-bisabolol formulation
Trial: 26280699
Drug: Control cream
RxNorm normalized name: BENZOYL PEROXIDE 3 mg in 60 mL TOPICAL LIQUID [Acnecare Dermacontrol Cream]
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control cream (vitamin A, vitamin E, talc, and zinc oxide)
Trial: 23740278
Drug: High-volume haemofiltration
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-volume haemofiltration (HVHF) at 70 mL/kg/h
Trial: 23740278
Drug: Standard-volume haemofiltration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-volume haemofiltration (SVHF) at 35 mL/kg/h
Trial: 21376385
Drug: Eribulin mesilate
RxNorm normalized name: Eribulin mesilate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eribulin mesilate (1·4 mg/m² administered intravenously during 2‐5 min on days 1 and 8 of a 21‐day cycle)
Trial: 16491283
Drug: hPTH(1-34) treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hPTH(1-34) treatment
Trial: 11314498
Drug: Helmet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helmet treatment
Trial: 11314498
Drug: Nonhelmet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonhelmet treatment
Trial: 8857040
Drug: Oral bile
RxNorm normalized name: bile salts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral bile salts (500 mg of sodium deoxycholate 8-hourly for 48 hours preoperatively)
Trial: 27768792
Drug: DEX implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEX implant (4 monthly)
Trial: 27768792
Drug: Bevacizumab (monthly,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (monthly, pro re nata)
Trial: 23036921
Drug: Amoxicillin 3g
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin 3g per os
Trial: 11996639
Drug: Protease inhibitor-based
RxNorm normalized name: Protease inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protease inhibitor-based regimens (e.g., indinavir)
Trial: 16392280
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (without beta‐blockers)
Trial: 12356784
Drug: Oral arginine
RxNorm normalized name: Arginine
DrugBank: Arginine (DB00125)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral arginine (3 grams per hour for 10 hours)
Trial: 7787408
Drug: Amino acid-enriched
RxNorm normalized name: silk amino acids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid-enriched glucose-insulin-potassium infusion (group A)
Trial: 375436
Drug: Conventional antacid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antacid therapy
Trial: 31793171
Drug: AZD5718 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5718 (200 mg) coadministered with Rosuvastatin (10 mg)
Trial: 31793171
Drug: AZD5718 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5718 (200 mg) as tablets
Trial: 31793171
Drug: AZD5718 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5718 (200 mg) tablets after high-fat breakfast
Trial: 31793171
Drug: AZD5718 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD5718 (200 mg) once-daily
Trial: 23324408
Drug: Erythromycin 250
RxNorm normalized name: erythromycin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 250 mg orally QID
Trial: 23324408
Drug: Neomycin 1
RxNorm normalized name: neomycin 1 MG/MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neomycin 1 g orally QID
Trial: 20663992
Drug: AMG 221
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 221 (3, 30, or 100 mg)
Trial: 15584488
Drug: Ibuprofen (Advil)
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ibuprofen (Advil)
Trial: 15584488
Drug: Acetaminophen (Tylenol)
RxNorm normalized name: Acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (Tylenol)
Trial: 15584488
Drug: Naproxen and
RxNorm normalized name: naproxen and misoprostol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen and Ibuprofen
Trial: 15584488
Drug: All three
RxNorm normalized name: three-lobe sage extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All three medications
Trial: 11710407
Drug: 1200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 ml of distilled water (trial 2)
Trial: 11710407
Drug: 1200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 ml of Gatorade (trial 3)
Trial: 8000803
Drug: 8% red
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% red cell suspension with diluted commercial sera hyperimmune to Salmonellae and Yersinia, serovars O3 and O9
Trial: 3571772
Drug: L-649,923 (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-649,923 (1000 mg)
Trial: 27739263
Drug: Carica papaya
RxNorm normalized name: Carica papaya
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carica papaya leaf extract capsule (500 mg once daily for 5 days)
Trial: 27739263
Drug: Routine supportive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine supportive treatment
Trial: 23975179
Drug: Standard-dose cytarabine
RxNorm normalized name: Cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Standard-dose cytarabine and anthracycline with risk-adapted remission induction regimen (7+3)
Trial: 19035420
Drug: Functional ability
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional ability (measured using the Disabilities of the Arm, Shoulder, and Hand questionnaire and the short version of the Sequential Occupational Dexterity Assessment)
Trial: 15604591
Drug: Cisplatin monotherapy
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin monotherapy (37.5 mg/m² on days 1 + 2 of 4-week schedules)
Trial: 15604591
Drug: Cisplatin/Ifosfamide/5-Fluorouracil (PIF)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin/Ifosfamide/5-Fluorouracil (PIF) regimen (Cisplatin same as above, Ifosfamide 2 g/m², Mesna 0.5 g/m², 5-Fluorouracil 500 mg/m², Folinic acid 30 mg/m² on days 1 + 2, all on 4-week schedules)
Trial: 9389673
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (ERCP only if biliary sepsis or obstructive jaundice occurred)
Trial: 1914053
Drug: diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 10 mg (n = 31)
Trial: 1914053
Drug: propranolol 80
RxNorm normalized name: propranolol 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: propranolol 80 mg (n = 31)
Trial: 6456870
Drug: Buf-Puf epidermabrasion
RxNorm normalized name: giant puffball extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buf-Puf epidermabrasion in combination with benzoyl peroxide (BPO)
Trial: 6742394
Drug: Midazolam (0.17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.17 mg/kg)
Trial: 6742394
Drug: Diazepam (0.32
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.32 mg/kg)
Trial: 30014565
Drug: Active oral
RxNorm normalized name: Factive Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active oral appliance (OA)
Trial: 30014565
Drug: Sham oral
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham oral appliance (OA)
Trial: 22706631
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation (median daily doses of 1,400 IU)
Trial: 18580847
Drug: L-5-hydroxytryptophan (5-HTP)
RxNorm normalized name: L-5-HTP
DrugBank: Oxitriptan (DB02959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-5-hydroxytryptophan (5-HTP)
Trial: 1978873
Drug: Amoxycillin 500
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 500 mg plus probenecid 500 mg three times a day for 21 days
Trial: 1978873
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg twice a day for 21 days
Trial: 6989482
Drug: Discontinued therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinued therapy after completing three years of continuous complete remission
Trial: 26916717
Drug: Preoperative Chemotherapy
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative Chemotherapy (ChT)
Trial: 22252796
Drug: Dabigatran etexilate
RxNorm normalized name: Dabigatran etexilate
DrugBank: Dabigatran etexilate (DB06695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dabigatran etexilate 220 mg (test treatment)
Trial: 22252796
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg administered subcutaneously once daily for 3 days
Trial: 22252796
Drug: Enoxaparin pre-treatment
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin pre-treatment
Trial: 17621023
Drug: No preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preoperative medication (control group).
Trial: 15846258
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with unfractionated heparin (UFH) as adjunctive antithrombin therapy
Trial: 11598429
Drug: CBT +
RxNorm normalized name: Cannabidiol
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBT + Fluoxetine (FLX)
Trial: 9161352
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium (150 mg daily for 28 days)
Trial: 7966841
Drug: Smoking intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking intervention plus bronchodilator
Trial: 7966841
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (bronchodilator)
Trial: 28285617
Drug: Bee propolis
RxNorm normalized name: Bee propolis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bee propolis (300 mg three times a day for a total of 900 mg/d)
Trial: 28285617
Drug: Placebo (similar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (similar pills lacking propolis)
Trial: 28285617
Drug: No significant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No significant difference reported for other lipids or insulin resistance indices between the two groups.
Trial: 14592846
Drug: 900 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 900 mg/d vitamin E supplementation
Trial: 14592846
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment without vitamin E
Trial: 7002355
Drug: Aspirin (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (325 mg four times daily)
Trial: 7002355
Drug: Sulfinpyrazone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfinpyrazone (200 mg four times daily)
Trial: 3903504
Drug: Both aspirin
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Both aspirin and sulfinpyrazone
Trial: 20630944
Drug: Telmisartan (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (160 mg/day)
Trial: 8251051
Drug: Thiamine 3
RxNorm normalized name: thiamine 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiamine 3 to 8 g/day administered orally
Trial: 4022687
Drug: Solution A
RxNorm normalized name: I.V. SOLUTION ADDITIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution A (90 mmol/L sodium, 20 g/L glucose, bicarbonate)
Trial: 4022687
Drug: Solution B
RxNorm normalized name: DONISLECEL-JUJN RINSE SOLUTION BAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution B (50 mmol/L sodium, 20 g/L glucose, citrate)
Trial: 4022687
Drug: Solution C
RxNorm normalized name: Salt solution combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution C (30 mmol/L sodium, 20 g/L glucose, citrate)
Trial: 4022687
Drug: Solution D
RxNorm normalized name: KIT, PATCH, MEDICATED AND SOLUTION DROPS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution D (30 mmol/L sodium, 50 g/L glucose, citrate)
Trial: 30056415
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy program (Control group)
Trial: 18389608
Drug: Curation algorithm
RxNorm normalized name: oxymetazoline hydrochloride Nasal Spray [Duration]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curation algorithm for chronic gastritis after antihelicobacter therapy
Trial: 11530993
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg LJP 394 weekly
Trial: 11530993
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg LJP 394 weekly
Trial: 9272319
Drug: Desmopressin intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin intranasal spray (20 mg)
Trial: 9272319
Drug: Desmopressin intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin intranasal spray (40 mg)
Trial: 9272319
Drug: Desmopressin intranasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desmopressin intranasal spray
Trial: 3091196
Drug: Lay therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lay therapy treatment
Trial: 18257181
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Xianling Gubao Capsules
Trial: 12825105
Drug: Sildenafil citrate
RxNorm normalized name: Sildenafil Citrate
DrugBank: Sildenafil (DB00203)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sildenafil citrate (Viagra) 25, 50, or 100 mg
Trial: 10594466
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (MgS) - 12 mmol magnesium lactate daily for 1 month
Trial: 30938842
Drug: Vortioxetine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vortioxetine (10 mg/day for 1 week, then increasing to 20 mg/day)
Trial: 26860490
Drug: Combined epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined epidural analgesia with total intravenous anaesthesia (Group E)
Trial: 26860490
Drug: Total intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total intravenous anaesthesia (Group C)
Trial: 22825227
Drug: Selling syringes
RxNorm normalized name: marine non-gelling gelatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selling syringes to injection drug users (IDUs)
Trial: 19741485
Drug: Propofol infusion
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol infusion at rates of 10 to 160 mg . kg(‐1). h(‐1)
Trial: 18085142
Drug: Aricept, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aricept, 2.5 mg (oral administration)
Trial: 12364843
Drug: DVP +
RxNorm normalized name: Divalproex Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DVP + quetiapine (450 mg/day)
Trial: 9819796
Drug: R24 monoclonal
RxNorm normalized name: factor VIII
DrugBank: Beroctocog alfa (DB14473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R24 monoclonal antibody (0, 5, 25, 50 mg/m2) with IL-2/α-IFN
Trial: 9819796
Drug: R24 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: R24 treatment
Trial: 9819796
Drug: No R24
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No R24 treatment (control group)
Trial: 337773
Drug: elantrine added
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: elantrine added to L-dopa treatment
Trial: 337773
Drug: elantrine with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: elantrine with L-dopa (or Sinemet)
Trial: 1851071
Drug: Insulin withdrawal
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin withdrawal
Trial: 30506451
Drug: Insulin therapy
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin therapy after insulin withdrawal
Trial: 30506451
Drug: Insulin-controlled euglycaemia
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-controlled euglycaemia (control)
Trial: 28249150
Drug: Nemolizumab 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nemolizumab 2.0 mg/kg every 8 weeks
Trial: 18309155
Drug: Chlorthalidone-based antihypertensive
RxNorm normalized name: Chlorthalidone
DrugBank: Chlorthalidone (DB00310)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone-based antihypertensive regimen